Kathy Williams Chiang

Kathy Williams Chiang is Vice President of Business Insights at Wunderman Data Management. She is the co-author of Monetizing Your Data: A Guide to Turning Data into Profit-Driving Strategies and Solutions. Kathy is an established Business Analytics practitioner with expertise in guided analytics, analytic data mart development, and business planning. Prior to her current position at Wunderman Data Management, she consulted with Aspirent on numerous analytic projects for several multi-national clients, including IHG, Coca Cola, among others. She has also worked for multi-national corporations including Telecommu­nications Systems of Trinidad and Tobago, Acuity Brands Lighting, BellSouth International, and Portman Overseas. She holds a Bachelor of Science in Chemistry from Louisiana State University as well as a MBA from Tulane University.
Compete in Age of Analytics - DOCUMENT Strategy
March 16 2017
Data and analytics have redefined the way we compete. Data is a critical corporate asset that organizations are starting to monetize in new ways to get ahead of their competition. The bottom line? Companies...
  • Robotic Process Automation (RPA) has long been recognized as a tool that clicks buttons faster than humans, excelling at repetitive tasks like moving files or exporting reports
  • For decades, customer communications management (CCM) has focused on outbound engagement, such as statements, explanations of benefits (EOBs) and annual notifications of changes (ANOCs), delivered in
  • When I think about how far customer communications have evolved, it’s clear that we’ve entered a new era, one where the regulated document is moving from being an artifact of a transaction
  • How much do I owe?  How do I pay? Where’s my bill? Are any of your customers asking these questions? If so, it might be time to rethink your utility bills. 
  • Economic pressures, regulatory shifts and evolving consumer expectations are converging to create a complex environment for health insurers. Amid this turbulence, many payers are hesitant to invest in